Brain Tumor Res Treat.  2017 Apr;5(1):16-23. 10.14791/btrt.2017.5.1.16.

An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea, 2013

• Dho YS
• Jung KW
• Ha J
• Seo Y
• Park CK
• Won YJ
• Yoo H

• KMID: 2378300
• DOI: http://doi.org/10.14791/btrt.2017.5.1.16

Abstract

BACKGROUND
This report aims to provide accurate nationwide epidemiologic data on primary brain and central nervous system (CNS) tumors in the Republic of Korea. We updated the data by analyzing primary brain and CNS tumors diagnosed in 2013 using the data from the national cancer incidence database.
METHODS
Data on primary brain and CNS tumors diagnosed in 2013 were collected from the Korean Central Cancer Registry. Crude and age-standardized rates were calculated in terms of gender, age, and histological type.
RESULTS
A total of 11,827 patients were diagnosed with primary brain and CNS tumors in 2013. Brain and CNS tumors occurred in females more often than in males (female:male, 1.70:1). The most common tumor was meningioma (37.3%). Pituitary tumors (18.0%), gliomas (12.7%), and nerve sheath tumors (12.3%) followed in incidence. Glioblastomas accounted for 41.8% of all gliomas. In children (<19 years), sellar region tumors (pituitary and craniopharyngioma), embryonal/primitive/medulloblastoma, and germ cell tumors were the most common tumors.
CONCLUSION
This study should provide valuable information regarding the primary brain tumor epidemiology in Republic of Korea.

Keyword

Epidemiology; Brain; Central nervous system; Tumors; Registries; Korea

MeSH Terms

Brain
Brain Neoplasms*
Central Nervous System
Child
Epidemiology*
Female
Glioblastoma
Glioma
Humans
Incidence
Korea
Male
Meningioma
Neoplasms, Germ Cell and Embryonal
Nerve Sheath Neoplasms
Pituitary Neoplasms
Registries
Republic of Korea*

Figure

• 

  Fig. 1 Distribution of primary brain and CNS tumors according to sex and behavior, Republic of Korea, 2013. CNS, central nervous system.

• 

  Fig. 2 Distribution of all brain and CNS tumors according to topography, Republic of Korea, 2013. CNS, central nervous system.

• 

  Fig. 3 Distribution of primary brain and CNS tumors according to age for selected histology, Republic of Korea, 2013. CNS, central nervous system.

• 

  Fig. 4 Distribution of brain and CNS tumors according to the histology, Republic of Korea, 2013. NOS, not otherwise specified; CNS, central nervous system.

• 

  Fig. 5 Incidence according to sex and histology, Republic of Korea, 2013. NOS, not otherwise specified.

• 

  Fig. 6 Distribution of primary brain and CNS tumors according to histology in children, Republic of Korea, 2013. CNS, central nervous system; NOS, not otherwise specified.

Reference

1. Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organizatiol;2000.

2. Bauchet L, Rigau V, Mathieu-Daudé H, et al. French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol. 2007; 84:189–199.

3. Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol. 2014; 16:Suppl 4. iv1–iv63.

4. Kaneko S, Nomura K, Yoshimura T, Yamaguchi N. Trend of brain tumor incidence by histological subtypes in Japan: estimation from the Brain Tumor Registry of Japan, 1973-1993. J Neurooncol. 2002; 60:61–69.

5. Shin HR, Won YJ, Jung KW, et al. Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat. 2005; 37:325–331.

6. Lee CH, Jung KW, Yoo H, Park S, Lee SH. Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc. 2010; 48:145–152.

7. Jung KW, Ha J, Lee SH, Won YJ, Yoo H. An updated nationwide epidemiology of primary brain tumors in republic of Korea. Brain Tumor Res Treat. 2013; 1:16–23.

8. Committee of Brain Tumor Registry of Japan. Report of Brain Tumor Registry of Japan (1969-1996). Neurol Med Chir (Tokyo). 2003; 43 Suppl:i–vii. 1–111.

9. Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol. 2006; 8:27–37.

10. Johannesen TB, Angell-Andersen E, Tretli S, Langmark F, Lote K. Trends in incidence of brain and central nervous system tumors in Norway, 1970-1999. Neuroepidemiology. 2004; 23:101–109.

11. Wöhrer A, Waldhör T, Heinzl H, et al. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol. 2009; 95:401–411.

12. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2013. National Cancer Institute;Accessed January 30, 2016. at http://seer.cancer.gov/csr/1975_2013/.

13. International Agency for Research on Cancer. Annual report of national cancer registration. Cancer incidence in 2005 and survival for 1993-2005. Accessed September 10, 2008. at http://www.iarc.fr/.

14. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine;1960.

15. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. Accessed January 28, 2016. at http://www.globocan.iarc.fr.